Rothschild & Co Asset Management US’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $8.32M | Sell |
52,249
-6,568
| -11% | -$1.05M | 0.13% | 123 |
|
|
2022
Q3 | $7.84M | Sell |
58,817
-8,645
| -13% | -$1.15M | 0.13% | 128 |
|
|
2022
Q2 | $10.5M | Sell |
67,462
-4,143
| -6% | -$646K | 0.16% | 111 |
|
|
2022
Q1 | $11.1M | Sell |
71,605
-38,619
| -35% | -$6.01M | 0.14% | 126 |
|
|
2021
Q4 | $14M | Sell |
110,224
-1,008
| -0.9% | -$128K | 0.16% | 138 |
|
|
2021
Q3 | $14.5M | Sell |
111,232
-7,293
| -6% | -$950K | 0.18% | 143 |
|
|
2021
Q2 | $21.1M | Buy |
118,525
+4,667
| +4% | +$829K | 0.25% | 126 |
|
|
2021
Q1 | $18.7M | Sell |
113,858
-7,093
| -6% | -$1.17M | 0.23% | 130 |
|
|
2020
Q4 | $20M | Sell |
120,951
-24,265
| -17% | -$4M | 0.26% | 135 |
|
|
2020
Q3 | $20.7M | Sell |
145,216
-28,273
| -16% | -$4.03M | 0.37% | 118 |
|
|
2020
Q2 | $19.1M | Sell |
173,489
-25,208
| -13% | -$2.78M | 0.28% | 152 |
|
|
2020
Q1 | $19.8M | Sell |
198,697
-16,457
| -8% | -$1.64M | 0.31% | 126 |
|
|
2019
Q4 | $32.1M | Sell |
215,154
-9,072
| -4% | -$1.35M | 0.33% | 123 |
|
|
2019
Q3 | $28.7M | Sell |
224,226
-4,317
| -2% | -$553K | 0.31% | 136 |
|
|
2019
Q2 | $32.6M | Buy |
228,543
+98,491
| +76% | +$14M | 0.35% | 117 |
|
|
2019
Q1 | $18.6M | Buy |
130,052
+5,434
| +4% | +$777K | 0.2% | 194 |
|
|
2018
Q4 | $15.4M | Buy |
+124,618
| New | +$15.4M | 0.19% | 200 |
|